Investor insights
Sectors invested in
Funding rounds participated in
$50M sweet spot round size
Most of their 26 investments are in rounds between $30M and $65M
Investor type
Basic info
Industry
Sectors
Date founded
2016
Investments made
Evommune raised $50M on April 26, 2023
Investors: Amplitude Ventures, Andera Partners, SymBiosis, EQT Life Sciences and Arix Bioscience plc
Disc Medicine raised $54M on August 10, 2022
Investors: OrbiMed Advisors, Atlas Venture, Novo Holdings, 5AM Ventures and Arix Bioscience plc
Sorriso Pharmaceuticals raised $31M on December 22, 2021
Investors: Arix Bioscience plc
Depixus raised $34M on December 15, 2021
Investors: Casdin Capital, LLC, Lansdowne Partners and Arix Bioscience plc
Disc Medicine raised $90M on September 2, 2021
Investors: Willett Advisors LLC, Atlas Venture, OrbiMed Advisors, Novo Holdings and Arix Bioscience plc
Aura Biosciences raised $80M on March 22, 2021
Investors: COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U., Chiesi Ventures, Lundbeckfonden / Lundbeck Foundation, Advent Life Sciences, Ysios Capital, Surveyor Capital, Medicxi and Arix Bioscience plc
GenSight Biologics raised $25M on October 22, 2020
Investors: The Invus Group, Sofinnova Partners and Arix Bioscience plc
Amplyx Pharmaceuticals, Inc raised $53M on May 19, 2020
Investors: Lundbeckfonden / Lundbeck Foundation, RiverVest Venture Partners, Adage Capital Management, Pappas Capital, Sofinnova Ventures, Russia technology fund and Arix Bioscience plc
Quench Bio raised $50M on January 27, 2020
Investors: RA Capital Management, L.P., Atlas Venture and Arix Bioscience plc
Stipe Therapeutics raised $22M on September 30, 2019
Investors: Novo Holdings, Wellington Partners and Arix Bioscience plc